Auramycin B

Auramycin B, an anthracycline antibiotic that shows marked antibacterial activity against Gram-positive bacteria. Auramycin B also exhibits antitumor activity against P388 and L1210 leukemia in mice[1].

Product Specifications

CAS Number

[78173-91-8]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Field of Research

Cancer; Infection

Smiles

COC([C@@H]([C@](O)(C1)C)C(C=C2C(C(C3=C(O)C=CC=C3C2=O)=O)=C4O)=C4[C@H]1O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@]7([H])[C@@](O[C@@]8([H])[C@@](CC([C@@H](O8)C)=O)([H])O7)([H])[C@@H](O6)C)N(C)C)=O

Molecular Formula

C41H49NO15

Molecular Weight

795.83

References & Citations

[1]Fujiwara A, et al. New anthracycline antibiotics, auramycins and sulfurmycins. I. Isolation and characterization of auramycins A and B, and sulfurmycins A and B. J Antibiot (Tokyo) . 1982 Feb;35 (2) :164-75.